These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 23406561)
1. Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma? Dalla Pria A; Hayward K; Bower M Expert Rev Anticancer Ther; 2013 Feb; 13(2):203-9. PubMed ID: 23406561 [TBL] [Abstract][Full Text] [Related]
2. Facing up to the ongoing challenge of Kaposi's sarcoma. Robey RC; Bower M Curr Opin Infect Dis; 2015 Feb; 28(1):31-40. PubMed ID: 25490104 [TBL] [Abstract][Full Text] [Related]
3. Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma. Bower M; Dalla Pria A; Coyle C; Andrews E; Tittle V; Dhoot S; Nelson M J Clin Oncol; 2014 Feb; 32(5):409-14. PubMed ID: 24378415 [TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma in sub-Saharan Africa: a current perspective. Mosam A; Aboobaker J; Shaik F Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745 [TBL] [Abstract][Full Text] [Related]
5. AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa. Chu KM; Mahlangeni G; Swannet S; Ford NP; Boulle A; Van Cutsem G J Int AIDS Soc; 2010 Jul; 13():23. PubMed ID: 20615222 [TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy. Cattelan AM; CalabrĂ² ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928 [TBL] [Abstract][Full Text] [Related]
12. Steroid-exacerbated HIV-associated cutaneous Kaposi's sarcoma immune reconstitution inflammatory syndrome: 'Where a good intention turns bad'. Chabria S; Barakat L; Ogbuagu O Int J STD AIDS; 2016 Oct; 27(11):1026-9. PubMed ID: 26769754 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in KwaZulu-Natal, South Africa. Mosam A; Uldrick TS; Shaik F; Carrara H; Aboobaker J; Coovadia H Int J STD AIDS; 2011 Nov; 22(11):671-3. PubMed ID: 22096054 [TBL] [Abstract][Full Text] [Related]
14. Life-threatening exacerbation of Kaposi's sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome. Volkow PF; Cornejo P; Zinser JW; Ormsby CE; Reyes-TerĂ¡n G AIDS; 2008 Mar; 22(5):663-5. PubMed ID: 18317012 [No Abstract] [Full Text] [Related]
15. Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi's sarcoma: a real-life study. Dalu D; Fasola C; Ammoni L; De Francesco D; Cona MS; Rota S; Ferrario S; Gambaro A; Tosca N; Piva S; La Verde N J Chemother; 2021 Sep; 33(5):342-347. PubMed ID: 34060438 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi. Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E Trop Doct; 2008 Jan; 38(1):5-7. PubMed ID: 18302849 [TBL] [Abstract][Full Text] [Related]